James S. Miser, MD

● Chair Professor, College of Medical Sciences and Technology, Taipei Medical University, Taiwan
● Chief Medical Officer, Lixte Biotechnology Holdings, Inc., Pasadena, CA, USA
● Dr. Miser is an internationally recognized pediatric hematologist/oncologist with extensive experience in the clinical development of novel anticancer therapies for pediatric malignancies. Throughout Dr. Miser’s outstanding career, he has held numerous leadership positions including former Chairman, Division of Pediatrics, former Director, Department of Pediatric Hematology/Oncology, and most notably former President and Chief Executive Officer, and Chief Medical Officer, at City of Hope National Medical Center, Duarte, CA, USA.
● He was a member of the Soft Tissue Sarcoma Strategy Group, and Member of the New Agents Executive and Steering Committee, Phase II Coordinator Children’s Cancer Group and Chairman, Data Monitoring Committee, National Wilms Tumor Society. He has authored >100 peer-reviewed scientific publications, many of which focus on pediatric clinical cancer studies.
● Dr. Miser’s medical training, residency and fellowship training were carried out at The University of Washington, Seattle, WA, USA